These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38010733)

  • 41. Pediatric oncologist willingness to offer germline TP53 testing in osteosarcoma.
    Shaul E; Roth M; Lo Y; Geller DS; Hoang B; Yang R; Malkin D; Gorlick R; Gill J
    Cancer; 2018 Mar; 124(6):1242-1250. PubMed ID: 29313943
    [TBL] [Abstract][Full Text] [Related]  

  • 42. p53 Frameshift Mutations Couple Loss-of-Function with Unique Neomorphic Activities.
    Tong DR; Zhou W; Katz C; Regunath K; Venkatesh D; Ihuegbu C; Manfredi JJ; Laptenko O; Prives C
    Mol Cancer Res; 2021 Sep; 19(9):1522-1533. PubMed ID: 34045312
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma.
    Gokgoz N; Wunder JS; Mousses S; Eskandarian S; Bell RS; Andrulis IL
    Cancer; 2001 Oct; 92(8):2181-9. PubMed ID: 11596036
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
    Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
    Elife; 2016 Apr; 5():. PubMed ID: 27070462
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mutation spectrum of p53 gene in highly malignant human osteosarcomas.
    Radig K; Schneider-Stock R; Oda Y; Neumann W; Mittler U; Roessner A
    Gen Diagn Pathol; 1996 Jun; 142(1):25-32. PubMed ID: 8793483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A; Vazna A; Hrachovina O; Bendova S; Prochazkova K; Sedlacek Z
    Cancer Genet Cytogenet; 2009 Aug; 193(1):63-6. PubMed ID: 19602465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inactivation of the WNT5A Alternative Promoter B Is Associated with DNA Methylation and Histone Modification in Osteosarcoma Cell Lines U2OS and SaOS-2.
    Vaidya H; Rumph C; Katula KS
    PLoS One; 2016; 11(3):e0151392. PubMed ID: 26978652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation.
    Szołtysek K; Janus P; Zając G; Stokowy T; Walaszczyk A; Widłak W; Wojtaś B; Gielniewski B; Cockell S; Perkins ND; Kimmel M; Widlak P
    BMC Genomics; 2018 Nov; 19(1):813. PubMed ID: 30419821
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms in TP53 are associated with risk and survival of osteosarcoma in a Chinese population.
    Ru JY; Cong Y; Kang WB; Yu L; Guo T; Zhao JN
    Int J Clin Exp Pathol; 2015; 8(3):3198-203. PubMed ID: 26045840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NFIB promotes cell survival by directly suppressing p21 transcription in TP53-mutated triple-negative breast cancer.
    Liu RZ; Vo TM; Jain S; Choi WS; Garcia E; Monckton EA; Mackey JR; Godbout R
    J Pathol; 2019 Feb; 247(2):186-198. PubMed ID: 30350349
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Screening for TP53 mutations in osteosarcomas using constant denaturant gel electrophoresis (CDGE).
    Smith-Sørensen B; Gebhardt MC; Kloen P; McIntyre J; Aguilar F; Cerutti P; Børresen AL
    Hum Mutat; 1993; 2(4):274-85. PubMed ID: 8401536
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Whole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data.
    Reimann E; Kõks S; Ho XD; Maasalu K; Märtson A
    Hum Genomics; 2014 Dec; 8(1):20. PubMed ID: 25496518
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant transformation of fibrous dysplasia into osteosarcoma confirmed with TP53 somatic mutation and mutational analysis of GNAS gene.
    Yap FHX; Amanuel B; Van Vliet C; Thomas M; Wong D
    Pathology; 2021 Aug; 53(5):652-654. PubMed ID: 33272697
    [No Abstract]   [Full Text] [Related]  

  • 55. Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients.
    Patiño-García A; Sierrasesúmaga L
    Cancer Genet Cytogenet; 1997 Oct; 98(1):50-5. PubMed ID: 9309118
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    Sakthikumar S; Elvers I; Kim J; Arendt ML; Thomas R; Turner-Maier J; Swofford R; Johnson J; Schumacher SE; Alföldi J; Axelsson E; Couto CG; Kisseberth WC; Pettersson ME; Getz G; Meadows JRS; Modiano JF; Breen M; Kierczak M; Forsberg-Nilsson K; Marinescu VD; Lindblad-Toh K
    Cancer Res; 2018 Jul; 78(13):3421-3431. PubMed ID: 29724721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR‑181b‑p53 negative feedback axis regulates osteosarcoma cell proliferation and invasion.
    Wan J; Long F; Zhang C; Liu Y
    Int J Mol Med; 2020 Jun; 45(6):1803-1813. PubMed ID: 32236583
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular pathogenesis of osteosarcoma.
    Kansara M; Thomas DM
    DNA Cell Biol; 2007 Jan; 26(1):1-18. PubMed ID: 17263592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 60. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.